How do make sense of the results and designs of the various cardiovascular outcome trials, including the LEADER trial, in patients with T2D and what do you believe is the take home message?

How do make sense of the results and designs of the various cardiovascular outcome trials, including the LEADER trial, in patients with T2D and what do you believe is the take home message?

How do make sense of the results and designs of the various cardiovascular outcome trials, including the LEADER trial, in patients with T2D and what do you believe is the take home message?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Richard Pratley, MD

Richard Pratley, MD

Senior Investigator Translational Research Institute for Metabolism and Diabetes Medical Director, Florida Hospital Diabetes Institute (FHDI) Professor, Sanford-Burnham Medical Research Institute at Lake Nona Orlando, Florida